在非小细胞肺癌中新兴的目标
Jing Wang1, Layana Biglow1, Megan Baumgart1
1Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Lung Cancer (Auckland, N.Z.)
|September 15, 2025
概括
在非小细胞肺癌 (NSCLC) 中识别分子驱动突变改善了患者的生存率. 目前正在进行的研究正在寻找新的点和疗法,以使更多的肺癌患者受益.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 分子驱动突变是非小细胞肺癌 (NSCLC) 治疗的关键.
- 有针对性的疗法显著改善了一些NSCLC患者的生存率.
- 研究正在积极确定新的点,以提高治疗疗效.
研究的目的:
- 审查已知的NSCLC驱动突变的新疗法策略.
- 提供有关NSCLC治疗新兴分子点的数据.
主要方法:
- 关于NSCLC驱动突变和向治疗的最新研究的文献综述.
- 对新出现的分子标进行临床试验数据的分析.
主要成果:
- 已经确定了几种分子标,从而带来了新的治疗选择.
- 向疗法在特定的NSCLC患者子组中显示出改善的生存率.
- 新兴的标显示出在NSCLC治疗中更广泛应用的希望.
结论:
- 基于分子驱动突变的向疗法已经改变了NSCLC治疗.
- 对新型分子标的持续研究对于改善更多患者的治疗结果至关重要.
- 个性化医疗方法对于推进NSCLC治疗至关重要.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.6K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
11.0K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:39lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K